泓博医药 (301230.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(泓博医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2022年三季报2022年中报2021年年报2021年三季报2021年中报
上市前/上市后 上市前上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 332,128,900.74205,867,164.68448,213,754.22295,003,037.48189,434,178.77
 营业收入(元) 332,128,900.74205,867,164.68448,213,754.22295,003,037.48189,434,178.77
二、营业总成本(元) 290,735,543.04182,151,376.73361,321,684.82245,758,345.14159,281,792.42
 营业成本(元) 212,123,679.12128,079,315.86274,810,156.67187,789,054.87122,266,431.85
 研发费用(元) 22,445,995.1913,969,800.4917,144,397.209,455,752.755,532,246.69
 营业税金及附加(元) 1,250,925.54774,286.021,767,353.231,366,991.001,055,308.61
 销售费用(元) 5,023,159.402,699,683.565,242,176.573,487,834.762,339,241.86
 管理费用(元) 56,941,089.6840,735,373.0057,749,872.7741,872,929.7626,912,414.49
 财务费用(元) -7,049,305.89-4,107,082.204,607,728.381,785,782.001,176,148.92
  其中:利息费用(元) 3,642,255.872,451,367.56-1,552,431.44695,753.28
  其中:利息收入(元) 434,705.85195,684.07-556,257.5648,003.16
三、其他经营收益
 加:公允价值变动收益(元) -160,464.59-246,758.49397,682.96585,566.75437,621.70
 加:投资收益(元) 599,615.91471,449.811,801,778.62453,259.81-817.85
  其中:对联营企业和合营企业的投资收益(元) -732.01--1,690.19-817.85
 资产处置收益(元) --46,682.72--
 资产减值损失(元) -1,600,196.84-2,093,051.26-2,060,998.24-2,299,329.00-2,261,261.71
 信用减值损失(元) 323,017.16168,733.31-2,465,324.62-1,603,325.56-1,807,640.77
 其他收益(元) 1,463,191.201,257,274.102,052,760.381,044,646.74293,671.05
四、营业利润(元) 42,018,520.5423,273,435.4286,664,651.2247,425,511.0826,813,958.77
 加:营业外收入(元) 205,669.6780,883.0056,885.8220,885.8218,600.00
 减:营业外支出(元) 73,878.3654,319.69488,793.75160,127.4892,729.54
五、利润总额(元) 42,150,311.8523,299,998.7386,232,743.2947,286,269.4226,739,829.23
 减:所得税费用(元) 3,977,030.132,778,579.0712,656,126.047,219,874.414,262,749.20
六、净利润(元) 38,173,281.7220,521,419.6673,576,617.2540,066,395.0122,477,080.03
(一)按经营持续性分类
  持续经营净利润(元) 38,173,281.7220,521,419.66-40,066,395.0122,477,080.03
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 38,173,281.7220,521,419.6673,576,617.2540,066,395.0122,477,080.03
 扣除非经常性损益后的净利润(元) 36,468,400.0019,276,600.0070,228,600.0038,324,500.0021,847,400.00
七、每股收益
 一、基本每股收益(元) 0.660.361.280.700.39
 二、稀释每股收益(元) 0.660.361.280.700.39
八、其他综合收益(元) 19,924.8331,496.50--34,405.78-51,608.39
 归属于母公司股东的其他综合收益(元) 19,924.8331,496.50--34,405.78-51,608.39
九、综合收益总额(元) 38,193,206.5520,552,916.16-40,031,989.2322,425,471.64
 归属于母公司所有者的综合收益总额(元) 38,193,206.5520,552,916.16-40,031,989.2322,425,471.64
公告日期 2022-10-312022-09-302022-03-272022-10-312021-10-22
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院